Estimation of Relative Vaccine Effectiveness in Influenza: A Systematic Review of Methodology
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Estimation of Relative Vaccine Effectiveness in Influenza: A Systematic Review of Methodology
Authors
Keywords
-
Journal
EPIDEMIOLOGY
Volume 33, Issue 3, Pages 334-345
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-02-26
DOI
10.1097/ede.0000000000001473
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Waning vaccine effectiveness against influenza-associated hospitalizations among adults, 2015-2016 to 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network
- (2021) Jill M Ferdinands et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis
- (2021) Jason K.H. Lee et al. VACCINE
- Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-Derived Quadrivalent Inactivated Influenza Vaccines and High-Dose Trivalent Influenza Vaccine in Preventing Influenza-Related Medical Encounters in US Adults ≥65 Years During the 2017-2018 and 2018-2019 Influenza Seasons
- (2021) Constantina Boikos et al. CLINICAL INFECTIOUS DISEASES
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- The Causal Interpretation of “Overall Vaccine Effectiveness” in Test-Negative Studies
- (2021) Shuo Feng et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018–19 influenza season
- (2021) Stephen I. Pelton et al. VACCINE
- Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial
- (2021) Anand Krishnan et al. PLOS MEDICINE
- Effectiveness of the Cell–Derived Inactivated Quadrivalent Influenza Vaccine in Individuals at High Risk of Influenza Complications in the 2018-2019 US Influenza Season
- (2021) Constantina Boikos et al. Open Forum Infectious Diseases
- Effectiveness of the MF59‐adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta‐analysis
- (2021) Brenda L. Coleman et al. Influenza and Other Respiratory Viruses
- Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe – Results from the DRIVE EU study platform
- (2021) Anke L. Stuurman et al. VACCINE
- Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan
- (2021) Szu-Min Hsieh et al. Lancet Respiratory Medicine
- Relative and absolute effectiveness of high-dose and standard-dose influenza vaccine against influenza-related hospitalization among older adults — United States, 2015–2017
- (2020) Joshua D Doyle et al. CLINICAL INFECTIOUS DISEASES
- Relative effectiveness of influenza vaccines among the U.S. elderly, 2018-19
- (2020) Hector S Izurieta et al. JOURNAL OF INFECTIOUS DISEASES
- Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season
- (2020) Nicola P. Klein et al. PLoS One
- Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-Derived Quadrivalent Influenza Vaccines in Preventing Influenza-Like Illness in 2017-2018
- (2020) Constantina Boikos et al. CLINICAL INFECTIOUS DISEASES
- High-dose influenza vaccination and mortality among predominantly male, white, senior veterans, United States, 2012/13 to 2014/15
- (2020) Yinong Young-Xu et al. Eurosurveillance
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012–2013 Through 2017–2018
- (2020) Sara S Kim et al. CLINICAL INFECTIOUS DISEASES
- Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes
- (2020) Shengli Xia et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Relative vaccine efficacy of high-dose versus standard-dose influenza vaccines in preventing probable influenza in a Medicare Fee-for-Service population
- (2020) Misti Paudel et al. VACCINE
- Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015–16 to 2018–19
- (2020) G.K. Balasubramani et al. VACCINE
- A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017–18 influenza season
- (2020) Victoria Divino et al. VACCINE
- Evaluating the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to High-Dose Trivalent and Other Egg-Based Influenza Vaccines among Older Adults in the US during the 2017–2018 Influenza Season
- (2020) Stephen I. Pelton et al. Vaccines
- Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials
- (2020) Brian J Ward et al. LANCET
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
- (2020) Shengli Xia et al. LANCET INFECTIOUS DISEASES
- Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac – PROFISCOV: A structured summary of a study protocol for a randomised controlled trial
- (2020) Ricardo Palacios et al. Trials
- Comparative effectiveness of influenza vaccines among U.S. Medicare beneficiaries ages 65 years and older during the 2019-20 season
- (2020) Hector S Izurieta et al. CLINICAL INFECTIOUS DISEASES
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis
- (2019) Lauren C. Ramsay et al. BMC Medicine
- Live Attenuated and Inactivated Influenza Vaccine Effectiveness
- (2019) Jessie R. Chung et al. PEDIATRICS
- Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method
- (2019) Yinong Young-Xu et al. VACCINE
- Depletion of Susceptibles Bias in Analyses of Intra-season Waning of Influenza Vaccine Effectiveness
- (2019) G Thomas Ray et al. CLINICAL INFECTIOUS DISEASES
- Adjuvanted versus nonadjuvanted influenza vaccines and risk of hospitalizations for pneumonia and cerebro/cardiovascular events in the elderly
- (2019) Francesco Lapi et al. Expert Review of Vaccines
- Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged ≥65 Years
- (2019) Yun Lu et al. JOURNAL OF INFECTIOUS DISEASES
- Comparing influenza vaccine effectiveness between cell-derived and egg-derived vaccines, 2017–2018 influenza season
- (2019) Laurie DeMarcus et al. VACCINE
- Comparison of vaccine effectiveness against influenza hospitalization of cell-based and egg-based influenza vaccines, 2017–2018
- (2019) Katia J. Bruxvoort et al. VACCINE
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Comparative effectiveness of high dose versus adjuvanted influenza vaccine: A retrospective cohort study
- (2019) Robertus van Aalst et al. VACCINE
- The Use of Test-negative Controls to Monitor Vaccine Effectiveness
- (2019) Huiying Chua et al. EPIDEMIOLOGY
- Assessing the prior event rate ratio method via probabilistic bias analysis on a Bayesian network
- (2019) Edward W. Thommes et al. STATISTICS IN MEDICINE
- A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases
- (2018) Emily J Erbelding et al. JOURNAL OF INFECTIOUS DISEASES
- Relative Vaccine Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among Veterans Health Administration Patients
- (2018) Yinong Young-Xu et al. JOURNAL OF INFECTIOUS DISEASES
- Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada
- (2018) Sarah A. Buchan et al. JAMA Pediatrics
- Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial
- (2018) Timo Vesikari et al. Lancet Respiratory Medicine
- Intra-season Waning of Influenza Vaccine Effectiveness
- (2018) G Thomas Ray et al. CLINICAL INFECTIOUS DISEASES
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018
- (2018) Danuta M Skowronski et al. CLINICAL INFECTIOUS DISEASES
- Relative effectiveness of cell-cultured and egg-based influenza vaccines among the U.S. elderly, 2017–18
- (2018) Hector S Izurieta et al. JOURNAL OF INFECTIOUS DISEASES
- Repeated annual influenza vaccination and vaccine effectiveness: review of evidence
- (2017) Edward A. Belongia et al. Expert Review of Vaccines
- Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older
- (2017) Lisa M. Dunkle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015
- (2017) J. Puig-Barberà et al. VACCINE
- Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial
- (2017) Stefan Gravenstein et al. Lancet Respiratory Medicine
- Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness
- (2016) Sheena G. Sullivan et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Effect of Previous-Year Vaccination on the Efficacy, Immunogenicity, and Safety of High-Dose Inactivated Influenza Vaccine in Older Adults
- (2016) Carlos A. DiazGranados et al. CLINICAL INFECTIOUS DISEASES
- Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine
- (2016) J. R. Chung et al. PEDIATRICS
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- Clinical Effectiveness of Split-Virion Versus Subunit Trivalent Influenza Vaccines in Older Adults
- (2015) H. K. Talbot et al. CLINICAL INFECTIOUS DISEASES
- Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccination in Community-Dwelling Veterans
- (2015) Diane M. Richardson et al. CLINICAL INFECTIOUS DISEASES
- “Crude Vaccine Effectiveness” Is a Misleading Term in Test-negative Studies of Influenza Vaccine Effectiveness
- (2015) Sheena G. Sullivan et al. EPIDEMIOLOGY
- Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis
- (2015) Hector S Izurieta et al. LANCET INFECTIOUS DISEASES
- Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season
- (2015) Edward A. Belongia et al. VACCINE
- Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty
- (2015) Carlos A. DiazGranados et al. VACCINE
- Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines
- (2015) Carlos A. DiazGranados et al. VACCINE
- Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines
- (2014) Gerrit A. van Essen et al. Influenza and Other Respiratory Viruses
- Relative Efficacy of AS03-Adjuvanted Pandemic Influenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Efficacy Trial
- (2014) Terry Nolan et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
- (2014) Carlos A. DiazGranados et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health-Related Behaviors and Effectiveness of Trivalent Inactivated versus Live Attenuated Influenza Vaccine in Preventing Influenza-Like Illness among Young Adults
- (2014) Tabitha Woolpert et al. PLoS One
- Efficacy of live attenuated influenza vaccine against influenza illness in children as a function of illness severity
- (2014) Christopher S. Ambrose et al. VACCINE
- AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial
- (2013) Janet E McElhaney et al. LANCET INFECTIOUS DISEASES
- The test-negative design for estimating influenza vaccine effectiveness
- (2013) Michael L. Jackson et al. VACCINE
- Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern Italy
- (2012) S. Mannino et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: Safety, immunogenicity and relative efficacy during the 2009–2010 season
- (2012) Carlos A. DiazGranados et al. VACCINE
- Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children
- (2011) Timo Vesikari et al. NEW ENGLAND JOURNAL OF MEDICINE
- A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older
- (2011) Bruce D. Forrest et al. VACCINE
- The Efficacy of Live Attenuated and Inactivated Influenza Vaccines in Children as a Function of Time Postvaccination
- (2010) Christopher S. Ambrose et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines
- (2009) Arnold S. Monto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of the trivalent live attenuated vs. inactivated influenza vaccines among U.S. military service members
- (2009) Angelia A. Eick et al. VACCINE
- Instrumental Variables in Influenza Vaccination Studies: Mission Impossible?!
- (2009) Rolf H.H. Groenwold et al. VALUE IN HEALTH
- Instrumental Variable Analysis for Estimation of Treatment Effects With Dichotomous Outcomes
- (2008) J. A. Rassen et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Prevention of Symptomatic Seasonal Influenza in 2005–2006 by Inactivated and Live Attenuated Vaccines
- (2008) Suzanne E. Ohmit et al. JOURNAL OF INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started